Deep vein thrombosis classification scheme: Difference between revisions

Jump to navigation Jump to search
 
Line 43: Line 43:
* Travel
* Travel


It may also be associated with permanent risk factors such as;
It may also be associated with permanent risk factors such as:


* Hypercoaguable state (genetic predisposition)
* Hypercoaguable state (genetic predisposition)

Latest revision as of 14:53, 12 November 2019



Resident
Survival
Guide

Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Kashish Goel, M.D.; Rim Halaby, M.D. [3] ;Assistant Editor(s)-In-Chief: Justine Cadet

Deep Vein Thrombosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Deep vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Approach

Assessment of Clinical Probability and Risk Scores

Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Venography

CT

MRI

Other Imaging Findings

Treatment

Treatment Approach

Medical Therapy

IVC Filter

Invasive Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenario

Upper extremity DVT

Recurrence

Pregnancy

Trials

Landmark Trials

Case Studies

Case #1

Deep vein thrombosis classification scheme On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Deep vein thrombosis classification scheme

CDC on Deep vein thrombosis classification scheme

Deep vein thrombosis classification scheme in the news

Blogs on Deep vein thrombosis classification scheme

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Deep vein thrombosis classification scheme

Overview

Deep vein thrombosis (DVT) is classified based on the site of occlusion or clot formation into lower extremity DVT and upper extremity DVT. Lower extremity DVT can further be classified into proximal and distal. Symptoms presentation of DVT and complications are largely influenced by the location of the thrombus.

Classification

Classification Based on Site of Thrombus Formation

 
 
 
Deep vein thrombosis (DVT)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lower extremity DVT
 
Upper extremity DVT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proximal
(popliteal, femoral, and/or iliac veins)
 
Isolated distal
(calf veins)
 
 

In studies including symptomatic inpatients, 80% of DVTs are proximal and isolated distal DVT accounts for only 20% of all DVTs.[1][2][3]

Proximal Vein Thrombosis

Proximal vein thrombosis involves the proximal veins, including the popliteal, femoral, or iliac vein. Proximal vein thrombosis is responsible for the majority of acute pulmonary emboli and is associated with higher mortality.[4] Clinically, proximal vein thrombosis is considered severe, and it is more commonly associated with serious chronic diseases than distal DVT, such as:[5]

Shown below is the distribution of involved veins in proximal DVT:[3]

Distal Vein Thrombosis

Distal or calf deep vein thrombosis involves the infrapopliteal veins [ie, posterior tibial veins, peroneal veins, anterior tibial veins and muscular calf veins (soleal or gemellar veins)]. It is often associated with transient risk factors, such as:[4]

  • Recent surgery
  • Immobilization
  • Travel

It may also be associated with permanent risk factors such as:

  • Hypercoaguable state (genetic predisposition)
  • May Thurner Syndrome

Upper Extremity DVT

  • Risk of embolization in upper extremity DVT is less than that with lower extremity DVT.[9]

Classification Based on the Acuity of the Clinical Presentation

  • Subacute and acute DVT can be differentiated not only through the timing of the clinical presentation, bust also through ultrasound findings.[10]
  • Subacute thrombosis refers to thrombosis formation involving a narrowing of the vein involved and a hyperechogenic clot; flow may be partially obstructed by this narrowing.
  • Acute thrombosis can refer to:
  • A vein with a thrombus that is normal or, even, wider than usual with the contralateral side of the vein being unaffected.
  • A clot that, during ultrasound echos, is not dense.
  • A clot that may totally or partially obstruct blood flow.
  • In the evaluation of the upper extremity, the subclavian and brachiocephalic veins inability to be compressed may pose challenges for determining subacute versus acute status.

References

  1. Anand SS, Wells PS, Hunt D, Brill-Edwards P, Cook D, Ginsberg JS (1998). "Does this patient have deep vein thrombosis?". JAMA. 279 (14): 1094–9. PMID 9546569. Unknown parameter |month= ignored (help)
  2. Wells PS, Hirsh J, Anderson DR; et al. (1995). "Accuracy of clinical assessment of deep-vein thrombosis". Lancet. 345 (8961): 1326–30. PMID 7752753. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Cogo A, Lensing AW, Prandoni P, Hirsh J (1993). "Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound". Arch. Intern. Med. 153 (24): 2777–80. PMID 8257253. Unknown parameter |month= ignored (help)
  4. 4.0 4.1 Galanaud JP, Sevestre-Pietri MA, Bosson JL, Laroche JP, Righini M, Brisot D, Boge G, van Kien AK, Gattolliat O, Bettarel-Binon C, Gris JC, Genty C, Quere I (2009). "Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study". Thromb. Haemost. 102 (3): 493–500. doi:10.1160/TH09-01-0053. PMID 19718469. Retrieved 2011-12-14. Unknown parameter |month= ignored (help)
  5. Alberts JL, Hass CJ, Vitek JL, Okun MS (2008). "Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease". Exp Neurol. 214 (1): 1–5. doi:10.1016/j.expneurol.2008.07.019. PMC 2888769. PMID 18718469.
  6. 6.0 6.1 Joffe HV, Kucher N, Tapson VF, Goldhaber SZ (2004). "Upper-extremity deep vein thrombosis: a prospective registry of 592 patients". Circulation. 110 (12): 1605–11. doi:10.1161/01.CIR.0000142289.94369.D7. PMID 15353493. Retrieved 2012-10-07. Unknown parameter |month= ignored (help)
  7. Isma N, Svensson PJ, Gottsäter A, Lindblad B (2010). "Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality". Thromb Res. 125 (6): e335–8. doi:10.1016/j.thromres.2010.03.005. PMID 20406709.
  8. Muñoz FJ, Mismetti P, Poggio R, Valle R, Barrón M, Guil M; et al. (2008). "Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry". Chest. 133 (1): 143–8. doi:10.1378/chest.07-1432. PMID 17925416.
  9. 9.0 9.1 Kucher N (2011). "Clinical practice. Deep-vein thrombosis of the upper extremities". N Engl J Med. 364 (9): 861–9. doi:10.1056/NEJMcp1008740. PMID 21366477.
  10. Cassou-Birckholz MF, Engelhorn CA, Salles-Cunha SX, Engelhorn AL, Zanoni CC, Gosalan CJ; et al. (2011). "Assessment of deep venous thrombosis by grayscale median analysis of ultrasound images". Ultrasound Q. 27 (1): 55–61. doi:10.1097/RUQ.0b013e31820e157d. PMID 21343802.

Template:WH Template:WS